CIC
RLAY icon

Cornercap Investment Counsel’s Relay Therapeutics RLAY Stock Holding History

Cornercap Investment Counsel’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,811
Closed -$76.5K – 529
2024
Q3 		$76.5K Sell
10,811
-12,043
-53% -$90K 0.02% 494
2024
Q2 		$149K Sell
22,854
-234
-1% -$1.6K 0.02% 555
2024
Q1 		$192K Hold
23,088
– – 0.03% 571
2023
Q4 		$254K Hold
23,088
– – 0.04% 502
2023
Q3 		$194K Buy
+23,088
New +$248K 0.04% 494

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Cornercap Investment Counsel's RLAY Position: Q4 2024 in Review

Cornercap Investment Counsel sold out of Relay Therapeutics (RLAY) in Q4 2024, closing a stake of 10,811 shares — an estimated $76.5K sold.

Cornercap Investment Counsel first reported a position in RLAY in Q3 2023 and held it in 5 quarters. The position peaked at $254K in Q4 2023. 199 funds tracked by Wall St. Rank hold RLAY as of Q4 2024.

  • Cornercap Investment Counsel reported no remaining Relay Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 10,811 Relay Therapeutics shares in Q4 2024, an estimated $76.5K.
  • Cornercap Investment Counsel first reported a position in Relay Therapeutics in Q3 2023 and held it in 5 quarters.
  • Cornercap Investment Counsel's Relay Therapeutics position peaked at $254K in Q4 2023.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2024.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.